CD177 and Alzheimer disease: SorLA is hypothesized to impact atherosclerosis pathogenesis through internalization of cell surface receptors involved in smooth muscle cell migration, and in Alzheimer dementia, SorLA influences the intracellular trafficking and accumulation of toxic Tau and aβ protein (21, 34, 42–46).